title: Results of Goeckerman treatment for psoriasis in children: a 21-year retrospective review.
abstract: Goeckerman treatment has been used for the management of widespread psoriasis in children for several decades at Mayo Clinic. We aimed to review our institutional experience with the effectiveness of Goeckerman treatment for psoriasis in children. We retrospectively reviewed the records of pediatric patients who underwent Goeckerman treatment over a 21-year period (1983-2003). The main outcome measure was improvement in psoriasis. During the study period, 65 children received Goeckerman treatment for predominantly widespread, recalcitrant psoriasis. The mean age was 11.6 years (range, 3 mos to 18 yrs), and the female-to-male ratio was 2:1. Psoriasis improved in all patients: 55 patients (85%) had >80% clearance of their psoriasis. The only adverse effect was folliculitis, occurring in 27 patients (42%). Mean duration of follow-up was 2.6 years (range, 17 days-18.2 yrs); average duration of remission was 2.6 years (range, 2 mos-12.79 yrs). Goeckerman treatment is an effective treatment for widespread psoriasis in children.
authors.affiliation: Department of Dermatology, Mayo Clinic, Rochester, Minnesota 55905, USA.
authors.forename: Kimberly R
authors.initials: KR
authors.lastname: Kortuem
authors.forename: Mark D P
authors.initials: MD
authors.lastname: Davis
authors.forename: Patricia M
authors.initials: PM
authors.lastname: Witman
authors.forename: Marian T
authors.initials: MT
authors.lastname: McEvoy
authors.forename: Sara A
authors.initials: SA
authors.lastname: Farmer
mesh_terms: D000293:Adolescent; D001458:Bandages; D002648:Child; D002675:Child, Preschool; D003033:Coal Tar / Q000627:therapeutic use*; D016208:Databases, Factual; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D008297:Male; D010778:Photochemotherapy; D011565:Psoriasis / Q000188:drug therapy*; D012008:Recurrence; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D003033:Coal Tar